Brock R - Search Results

1

Lipolanthionine peptides act as inhibitors of TLR2-mediated IL-8 secretion. Synthesis and structure-activity relationships.

Seyberth T, Voss S, Brock R, Wiesmüller KH, Jung G. Seyberth T, et al. Among authors: brock r. J Med Chem. 2006 Mar 9;49(5):1754-65. doi: 10.1021/jm050585d. J Med Chem. 2006. PMID: 16509590

2

Lipopeptide structure determines TLR2 dependent cell activation level.

Buwitt-Beckmann U, Heine H, Wiesmüller KH, Jung G, Brock R, Ulmer AJ. Buwitt-Beckmann U, et al. Among authors: brock r. FEBS J. 2005 Dec;272(24):6354-64. doi: 10.1111/j.1742-4658.2005.05029.x. FEBS J. 2005. PMID: 16336272 Free article.

3

The activity of lipopeptide TLR2 agonists critically depends on the presence of solubilizers.

Voss S, Ulmer AJ, Jung G, Wiesmüller KH, Brock R. Voss S, et al. Among authors: brock r. Eur J Immunol. 2007 Dec;37(12):3489-98. doi: 10.1002/eji.200737537. Eur J Immunol. 2007. PMID: 18034424 Free article.

4

Extending the applicability of carboxyfluorescein in solid-phase synthesis.

Fischer R, Mader O, Jung G, Brock R. Fischer R, et al. Among authors: brock r. Bioconjug Chem. 2003 May-Jun;14(3):653-60. doi: 10.1021/bc025658b. Bioconjug Chem. 2003. PMID: 12757391

5

Synthetic lipopeptide adjuvants and Toll-like receptor 2--structure-activity relationships.

Spohn R, Buwitt-Beckmann U, Brock R, Jung G, Ulmer AJ, Wiesmüller KH. Spohn R, et al. Among authors: brock r. Vaccine. 2004 Jun 23;22(19):2494-9. doi: 10.1016/j.vaccine.2003.11.074. Vaccine. 2004. PMID: 15193414

6

Chemolabile cellular microarrays for screening small molecules and peptides.

Hoff A, André T, Fischer R, Voss S, Hulko M, Marquardt U, Wiesmüller KH, Brock R. Hoff A, et al. Among authors: brock r. Mol Divers. 2004;8(3):311-20. doi: 10.1023/b:modi.0000036241.85469.85. Mol Divers. 2004. PMID: 15384424

7

Toll-like receptor 6-independent signaling by diacylated lipopeptides.

Buwitt-Beckmann U, Heine H, Wiesmüller KH, Jung G, Brock R, Akira S, Ulmer AJ. Buwitt-Beckmann U, et al. Among authors: brock r. Eur J Immunol. 2005 Jan;35(1):282-9. doi: 10.1002/eji.200424955. Eur J Immunol. 2005. PMID: 15580661 Free article.

8

A CD14 domain with lipopolysaccharide-binding and -neutralizing activity.

Voss S, Welte S, Fotin-Mleczek M, Fischer R, Ulmer AJ, Jung G, Wiesmüller KH, Brock R. Voss S, et al. Among authors: brock r. Chembiochem. 2006 Feb;7(2):275-86. doi: 10.1002/cbic.200500257. Chembiochem. 2006. PMID: 16444757

9

TLR1- and TLR6-independent recognition of bacterial lipopeptides.

Buwitt-Beckmann U, Heine H, Wiesmüller KH, Jung G, Brock R, Akira S, Ulmer AJ. Buwitt-Beckmann U, et al. Among authors: brock r. J Biol Chem. 2006 Apr 7;281(14):9049-57. doi: 10.1074/jbc.M512525200. Epub 2006 Feb 2. J Biol Chem. 2006. PMID: 16455646 Free article.

10

Molecular basis for the recognition of two structurally different major histocompatibility complex/peptide complexes by a single T-cell receptor.

Brock R, Wiesmüller KH, Jung G, Walden P. Brock R, et al. Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):13108-13. doi: 10.1073/pnas.93.23.13108. Proc Natl Acad Sci U S A. 1996. PMID: 8917552 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,001 results

Search Page

Filters